Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.

Russell, Beth; White, Benjamin E; Rous, Brian; Wong, Kwok; Bouvier Ellis, Catherine; Srirajaskanthan, Rajaventhan; Van Hemelrijck, Mieke; Ramage, John K

Russell, Beth; White, Benjamin E; Rous, Brian; Wong, Kwok; Bouvier Ellis, Catherine; Srirajaskanthan, Rajaventhan; Van Hemelrijck, Mieke; Ramage, John K.

Affiliation

Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
White BE; Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
Rous B; NHS Digital, 7 and 8 Wellington Place, Leeds, UK.
Wong K; NHS Digital, 7 and 8 Wellington Place, Leeds, UK.
Bouvier Ellis C; Neuroendocrine Cancer UK, Holly House, Leamington Spa, UK.
Srirajaskanthan R; King's Health Partners Neuroendocrine ENETS Centre of Excellence, King's College Hospital, London, UK.
Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Ramage JK; Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.

Neuroendocrinology ; 113(8): 811-821, 2023.

Article in En | MEDLINE | ID: mdl-36940675

Subject(s)
Key words

Metachronous tumour; Neuroendocrine neoplasm; Neuroendocrine tumour; Standardized incidence ratio

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Thyroid Neoplasms / Neoplasms, Second Primary / Neuroendocrine Tumors Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Neuroendocrinology Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google